Cardio Diagnostics Inc. (CDIO)
0.57
-0.06 (-9.24%)
At close: Jan 14, 2025, 3:59 PM
0.60
5.02%
Pre-market Jan 15, 2025, 07:16 AM EST
undefined% (undefined)
| Bid | 0.57 |
| Market Cap | 23.05M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.3 |
| PE Ratio (ttm) | -1.9 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 0.6 |
| Volume | 733,690 |
| Avg. Volume (20D) | 6,731,804 |
| Open | 0.59 |
| Previous Close | 0.63 |
| Day's Range | 0.55 - 0.61 |
| 52-Week Range | 0.19 - 2.83 |
| Beta | undefined |
About CDIO
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois....
Industry Biotechnology
Sector Healthcare
IPO Date Jan 14, 2022
Employees 7
Stock Exchange NASDAQ
Ticker Symbol CDIO
Website https://cardiodiagnosticsinc.com
Analyst Forecast
According to 2 analyst ratings, the average rating for CDIO stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 50.00%
Hold 0.00%
Sell 0.00%
Next Earnings Release
Cardio Diagnostics Inc. is scheduled to release its earnings on Mar 31, 2025,
during market hours.
Analysts project revenue of $25.00K, reflecting a 370.81% YoY growth and earnings per share of -0.06.
Analysts project revenue of $25.00K, reflecting a 370.81% YoY growth and earnings per share of -0.06.
10 months ago ·
Source
+22.48%
Cardio Diagnostics Holdings shares are trading hig...
Unlock content with
Pro Subscription
